Modern treatments for tuberculosis (TB) have benefited greatly from the fastdeveloping science of nanomedicine. Nanotechnology has created new avenues for the treatment of tuberculosis in modern medicine. The application of nanotechnology to TB treatment offers encouraging opportunities for better drug delivery, individualized medication, and more efficient disease management. By requiring fewer drug dosages, less frequent administration, and shorter treatment durations, nanomedicines may enhance the results of tuberculosis (TB) treatment. Future TB nanomedicines are anticipated to heavily rely on novel strategies, including polymer-drug formulations for drug delivery and nanoparticle systems that can influence macrophages' immunological response and deliver pharmaceuticals intracellularly. However, given the difficulties in creating novel antituberculosis medications, nanomedicine offers a viable basis for addressing TB.
Dixit et al. (2026) studied this question.